Japan Intellectual Property Rights: AGENTS, PHARMACEUTICALS, AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING GROWTH OF CD20-POSITIVE CANCER CELLS RESISTANT TO TYPE II ANTI-CD20 ANTIBODY AND FOR TREATING CD20-POSITIVE CANCER RESISTANT TO TYPE II ANTI-CD20 ANTIBODY

Japan, Oct. 30 -- CHUGAI PHARMACEUT CO LTD has got intellectual property rights for 'AGENTS, PHARMACEUTICALS, AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING GROWTH OF CD20-POSITIVE CANCER CELLS RESISTANT TO TYPE II ANTI-CD20 ANTIBODY AND FOR TREATING CD20-POSITIVE CANCER RESISTANT TO TYPE II ANTI-CD20 ANTIBODY.' Other related details are as follows:

Application Number: JP,2021-158769

Category (FI): A61K31/4184,C12N15/13,A61K39/395@N,A61K39/395@D,A61P43/00,121,A61P35/00,C07K16/28

Stage: Grant (IP right document published.)

Filing Date: Sept. 29, 2021

Publication Date: April 11, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....